REG1V.HE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:29):

Stats
Today's Volume	43 933.00
Average Volume	27 375.00
Market Cap	634.50M
EPS	€0 ( 2024-04-24 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	33.14
ATR14	€0.0440 (0.18%)

Volume Correlation

Long: -0.11 (neutral)

Short: 0.19 (neutral)

Signal:(46.178) Neutral

Revenio Group Oyj Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Revenio Group Oyj Correlation - Currency/Commodity

0.59
( weak )

-0.29
( neutral )

0.00
( neutral )

0.68
( moderate )

-0.36
( neutral )

-0.68
( moderate negative )

Revenio Group Oyj Financials

Annual	2023
Revenue:	€96.60M
Gross Profit:	€45.30M (46.89 %)
EPS:	€0.720

Q4	2023
Revenue:	€29.10M
Gross Profit:	€14.70M (50.52 %)
EPS:	€0.270

Q3	2023
Revenue:	€22.00M
Gross Profit:	€15.60M (70.91 %)
EPS:	€0.170

Q2	2023
Revenue:	€22.30M
Gross Profit:	€15.90M (71.30 %)
EPS:	€0.120

Financial Reports:

No articles found.

Revenio Group Oyj

Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.